美秀從波士頓來，分享新藥研發的幾個故事

A couple of stories in drug development (藥物研發的故事)

Dr. Mei-Hsiu Ling (中文演講)

Drug development is a lengthy and expensive process. It usually starts with a sound scientific theory. There are extensive experiments in the lab, on animals before a compound can be tested on humans. To bring an effective treatment to patients, it needs to succeed in all the phases of experiments in humans. There are successes and failures. In this session, I will review a couple of recent stories.

Bio of Dr. Mei-Hsiu Ling

https://a248.e.akamai.net/secure.meetupstatic.com/photos/event/c/2/f/7/600_456529911.jpeg

Mei-Hsiu Ling joined Vertex in 2012 as the Biostatistics head for Hepatitis C franchise and currently leads the Cystic Fibrosis franchise and is the department head for the statistical programming group.

Prior to joining Vertex, Dr. Ling was Global Program Head of Respiratory franchise at Novartis. She has more than 20 years of experience in late phase drug development. She has a Ph.D. in Statistics from U.C. Berkeley and a B.S. in Mathematics from National Tsing Hua University, Taiwan.

She is a board of director (and the president, 2016) for Monte Jade New England (mj-ne.org) and will serve as an executive committee member for Global Monte Jade in 2017.

主辦：波士頓--台灣知識交流平台(Boston-Taiwan Platform)、清大圖書館

協辦：清大校友服務中心、清大校友會